R. Zumschlinge

Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.

U. Gatzemeier, I. Bruns, K. Dalhoff, 2003, Lung cancer.

Ifosfamide, carboplatin and etoposide combined with 41.8 °C whole body hyperthermia for malignant pleural mesothelioma

U. Gatzemeier, I. Bruns, K. Dalhoff, 2003 .

Oxaliplatin plus 5FU/folinic acid (FUFOX regimen) in 1st line metastatic gastric cancer (MGC). Results of the Multicenter Phase II STOMOX Trial

F. Lordick, C. Peschel, J. Duyster, 2005 .

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

F. Lordick, C. Peschel, J. Duyster, 2005, British Journal of Cancer.

Current status of radiant whole-body hyperthermia at temperatures >41.5°C and practical guidelines for the treatment of adults. The German ‘Interdisciplinary Working Group on Hyperthermia’

P. Wust, H. Sommer, B. Hildebrandt, 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Randomized trial with ICE (ifosfamide, carboplatin, etoposide) plus whole body hyperthermia versus ICE chemotherapy for malignant pleural mesothelioma.

P. Zabel, K. Dalhoff, T. Wagner, 2004, Journal of Clinical Oncology.